Global Infectious Diseases Molecular Diagnostics Kit Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Infectious Diseases Molecular Diagnostics Kit market size was valued at US$ 30730 million in 2023. With growing demand in downstream market, the Infectious Diseases Molecular Diagnostics Kit is forecast to a readjusted size of US$ 51910 million by 2030 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Infectious Diseases Molecular Diagnostics Kit market. Infectious Diseases Molecular Diagnostics Kit are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infectious Diseases Molecular Diagnostics Kit. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infectious Diseases Molecular Diagnostics Kit market.
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Infectious Diseases Molecular Diagnostics Kit market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Infectious Diseases Molecular Diagnostics Kit market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction PCR, Molecular Hybridization), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infectious Diseases Molecular Diagnostics Kit market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Infectious Diseases Molecular Diagnostics Kit market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Infectious Diseases Molecular Diagnostics Kit industry. This include advancements in Infectious Diseases Molecular Diagnostics Kit technology, Infectious Diseases Molecular Diagnostics Kit new entrants, Infectious Diseases Molecular Diagnostics Kit new investment, and other innovations that are shaping the future of Infectious Diseases Molecular Diagnostics Kit.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infectious Diseases Molecular Diagnostics Kit market. It includes factors influencing customer ' purchasing decisions, preferences for Infectious Diseases Molecular Diagnostics Kit product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infectious Diseases Molecular Diagnostics Kit market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infectious Diseases Molecular Diagnostics Kit market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infectious Diseases Molecular Diagnostics Kit market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infectious Diseases Molecular Diagnostics Kit industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infectious Diseases Molecular Diagnostics Kit market.
Market Segmentation:
Infectious Diseases Molecular Diagnostics Kit market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Infectious Diseases Molecular Diagnostics Kit market size was valued at US$ 30730 million in 2023. With growing demand in downstream market, the Infectious Diseases Molecular Diagnostics Kit is forecast to a readjusted size of US$ 51910 million by 2030 with a CAGR of 7.8% during review period.
The research report highlights the growth potential of the global Infectious Diseases Molecular Diagnostics Kit market. Infectious Diseases Molecular Diagnostics Kit are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Infectious Diseases Molecular Diagnostics Kit. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Infectious Diseases Molecular Diagnostics Kit market.
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Infectious Diseases Molecular Diagnostics Kit market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Infectious Diseases Molecular Diagnostics Kit market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction PCR, Molecular Hybridization), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Infectious Diseases Molecular Diagnostics Kit market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Infectious Diseases Molecular Diagnostics Kit market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Infectious Diseases Molecular Diagnostics Kit industry. This include advancements in Infectious Diseases Molecular Diagnostics Kit technology, Infectious Diseases Molecular Diagnostics Kit new entrants, Infectious Diseases Molecular Diagnostics Kit new investment, and other innovations that are shaping the future of Infectious Diseases Molecular Diagnostics Kit.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Infectious Diseases Molecular Diagnostics Kit market. It includes factors influencing customer ' purchasing decisions, preferences for Infectious Diseases Molecular Diagnostics Kit product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Infectious Diseases Molecular Diagnostics Kit market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Infectious Diseases Molecular Diagnostics Kit market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Infectious Diseases Molecular Diagnostics Kit market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Infectious Diseases Molecular Diagnostics Kit industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Infectious Diseases Molecular Diagnostics Kit market.
Market Segmentation:
Infectious Diseases Molecular Diagnostics Kit market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Polymerase Chain Reaction PCR
- Molecular Hybridization
- Biochip
- Others
- Hospital
- Third-party Testing Agency
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Qiagen
- Illumina
- Abbott
- Hologic
- BioMerieux
- Danaher (Cepheid)
- Myriad Genetics
- DAAN Gene
- Agilent
- Genomic Health
- BD
- Foundation Medicine
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2030
2.1.2 Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Infectious Diseases Molecular Diagnostics Kit Segment by Type
2.2.1 Polymerase Chain Reaction PCR
2.2.2 Molecular Hybridization
2.2.3 Biochip
2.2.4 Others
2.3 Infectious Diseases Molecular Diagnostics Kit Market Size by Type
2.3.1 Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
2.4 Infectious Diseases Molecular Diagnostics Kit Segment by Application
2.4.1 Hospital
2.4.2 Third-party Testing Agency
2.4.3 Others
2.5 Infectious Diseases Molecular Diagnostics Kit Market Size by Application
2.5.1 Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
3 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET SIZE BY PLAYER
3.1 Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Players
3.1.1 Global Infectious Diseases Molecular Diagnostics Kit Revenue by Players (2019-2024)
3.1.2 Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Diseases Molecular Diagnostics Kit Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT BY REGIONS
4.1 Infectious Diseases Molecular Diagnostics Kit Market Size by Regions (2019-2024)
4.2 Americas Infectious Diseases Molecular Diagnostics Kit Market Size Growth (2019-2024)
4.3 APAC Infectious Diseases Molecular Diagnostics Kit Market Size Growth (2019-2024)
4.4 Europe Infectious Diseases Molecular Diagnostics Kit Market Size Growth (2019-2024)
4.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024)
5.2 Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)
5.3 Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2019-2024)
6.2 APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)
6.3 APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Diseases Molecular Diagnostics Kit by Country (2019-2024)
7.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)
7.3 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit by Region (2019-2024)
8.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)
8.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET FORECAST
10.1 Global Infectious Diseases Molecular Diagnostics Kit Forecast by Regions (2025-2030)
10.1.1 Global Infectious Diseases Molecular Diagnostics Kit Forecast by Regions (2025-2030)
10.1.2 Americas Infectious Diseases Molecular Diagnostics Kit Forecast
10.1.3 APAC Infectious Diseases Molecular Diagnostics Kit Forecast
10.1.4 Europe Infectious Diseases Molecular Diagnostics Kit Forecast
10.1.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Forecast
10.2 Americas Infectious Diseases Molecular Diagnostics Kit Forecast by Country (2025-2030)
10.2.1 United States Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.2.2 Canada Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.2.3 Mexico Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.2.4 Brazil Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3 APAC Infectious Diseases Molecular Diagnostics Kit Forecast by Region (2025-2030)
10.3.1 China Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.2 Japan Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.3 Korea Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.4 Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.5 India Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.6 Australia Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4 Europe Infectious Diseases Molecular Diagnostics Kit Forecast by Country (2025-2030)
10.4.1 Germany Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4.2 France Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4.3 UK Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4.4 Italy Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4.5 Russia Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Forecast by Region (2025-2030)
10.5.1 Egypt Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5.2 South Africa Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5.3 Israel Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5.4 Turkey Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5.5 GCC Countries Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.6 Global Infectious Diseases Molecular Diagnostics Kit Forecast by Type (2025-2030)
10.7 Global Infectious Diseases Molecular Diagnostics Kit Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Infectious Diseases Molecular Diagnostics Kit Product Offered
11.1.3 Roche Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Infectious Diseases Molecular Diagnostics Kit Product Offered
11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Infectious Diseases Molecular Diagnostics Kit Product Offered
11.3.3 Illumina Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Infectious Diseases Molecular Diagnostics Kit Product Offered
11.4.3 Abbott Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Main Business Overview
11.4.5 Abbott Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Infectious Diseases Molecular Diagnostics Kit Product Offered
11.5.3 Hologic Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Offered
11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Danaher (Cepheid)
11.7.1 Danaher (Cepheid) Company Information
11.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Offered
11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Danaher (Cepheid) Main Business Overview
11.7.5 Danaher (Cepheid) Latest Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Information
11.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Offered
11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Myriad Genetics Main Business Overview
11.8.5 Myriad Genetics Latest Developments
11.9 DAAN Gene
11.9.1 DAAN Gene Company Information
11.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Offered
11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 DAAN Gene Main Business Overview
11.9.5 DAAN Gene Latest Developments
11.10 Agilent
11.10.1 Agilent Company Information
11.10.2 Agilent Infectious Diseases Molecular Diagnostics Kit Product Offered
11.10.3 Agilent Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Agilent Main Business Overview
11.10.5 Agilent Latest Developments
11.11 Genomic Health
11.11.1 Genomic Health Company Information
11.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Offered
11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Genomic Health Main Business Overview
11.11.5 Genomic Health Latest Developments
11.12 BD
11.12.1 BD Company Information
11.12.2 BD Infectious Diseases Molecular Diagnostics Kit Product Offered
11.12.3 BD Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BD Main Business Overview
11.12.5 BD Latest Developments
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Information
11.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Offered
11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Foundation Medicine Main Business Overview
11.13.5 Foundation Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2030
2.1.2 Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Infectious Diseases Molecular Diagnostics Kit Segment by Type
2.2.1 Polymerase Chain Reaction PCR
2.2.2 Molecular Hybridization
2.2.3 Biochip
2.2.4 Others
2.3 Infectious Diseases Molecular Diagnostics Kit Market Size by Type
2.3.1 Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
2.4 Infectious Diseases Molecular Diagnostics Kit Segment by Application
2.4.1 Hospital
2.4.2 Third-party Testing Agency
2.4.3 Others
2.5 Infectious Diseases Molecular Diagnostics Kit Market Size by Application
2.5.1 Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
3 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET SIZE BY PLAYER
3.1 Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Players
3.1.1 Global Infectious Diseases Molecular Diagnostics Kit Revenue by Players (2019-2024)
3.1.2 Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Diseases Molecular Diagnostics Kit Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT BY REGIONS
4.1 Infectious Diseases Molecular Diagnostics Kit Market Size by Regions (2019-2024)
4.2 Americas Infectious Diseases Molecular Diagnostics Kit Market Size Growth (2019-2024)
4.3 APAC Infectious Diseases Molecular Diagnostics Kit Market Size Growth (2019-2024)
4.4 Europe Infectious Diseases Molecular Diagnostics Kit Market Size Growth (2019-2024)
4.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024)
5.2 Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)
5.3 Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2019-2024)
6.2 APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)
6.3 APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Infectious Diseases Molecular Diagnostics Kit by Country (2019-2024)
7.2 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)
7.3 Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit by Region (2019-2024)
8.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024)
8.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS KIT MARKET FORECAST
10.1 Global Infectious Diseases Molecular Diagnostics Kit Forecast by Regions (2025-2030)
10.1.1 Global Infectious Diseases Molecular Diagnostics Kit Forecast by Regions (2025-2030)
10.1.2 Americas Infectious Diseases Molecular Diagnostics Kit Forecast
10.1.3 APAC Infectious Diseases Molecular Diagnostics Kit Forecast
10.1.4 Europe Infectious Diseases Molecular Diagnostics Kit Forecast
10.1.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Forecast
10.2 Americas Infectious Diseases Molecular Diagnostics Kit Forecast by Country (2025-2030)
10.2.1 United States Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.2.2 Canada Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.2.3 Mexico Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.2.4 Brazil Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3 APAC Infectious Diseases Molecular Diagnostics Kit Forecast by Region (2025-2030)
10.3.1 China Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.2 Japan Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.3 Korea Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.4 Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.5 India Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.3.6 Australia Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4 Europe Infectious Diseases Molecular Diagnostics Kit Forecast by Country (2025-2030)
10.4.1 Germany Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4.2 France Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4.3 UK Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4.4 Italy Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.4.5 Russia Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5 Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Forecast by Region (2025-2030)
10.5.1 Egypt Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5.2 South Africa Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5.3 Israel Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5.4 Turkey Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.5.5 GCC Countries Infectious Diseases Molecular Diagnostics Kit Market Forecast
10.6 Global Infectious Diseases Molecular Diagnostics Kit Forecast by Type (2025-2030)
10.7 Global Infectious Diseases Molecular Diagnostics Kit Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Infectious Diseases Molecular Diagnostics Kit Product Offered
11.1.3 Roche Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Qiagen
11.2.1 Qiagen Company Information
11.2.2 Qiagen Infectious Diseases Molecular Diagnostics Kit Product Offered
11.2.3 Qiagen Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Qiagen Main Business Overview
11.2.5 Qiagen Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Infectious Diseases Molecular Diagnostics Kit Product Offered
11.3.3 Illumina Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Infectious Diseases Molecular Diagnostics Kit Product Offered
11.4.3 Abbott Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Main Business Overview
11.4.5 Abbott Latest Developments
11.5 Hologic
11.5.1 Hologic Company Information
11.5.2 Hologic Infectious Diseases Molecular Diagnostics Kit Product Offered
11.5.3 Hologic Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Hologic Main Business Overview
11.5.5 Hologic Latest Developments
11.6 BioMerieux
11.6.1 BioMerieux Company Information
11.6.2 BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Offered
11.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 BioMerieux Main Business Overview
11.6.5 BioMerieux Latest Developments
11.7 Danaher (Cepheid)
11.7.1 Danaher (Cepheid) Company Information
11.7.2 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Offered
11.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Danaher (Cepheid) Main Business Overview
11.7.5 Danaher (Cepheid) Latest Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Information
11.8.2 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Offered
11.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Myriad Genetics Main Business Overview
11.8.5 Myriad Genetics Latest Developments
11.9 DAAN Gene
11.9.1 DAAN Gene Company Information
11.9.2 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Offered
11.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 DAAN Gene Main Business Overview
11.9.5 DAAN Gene Latest Developments
11.10 Agilent
11.10.1 Agilent Company Information
11.10.2 Agilent Infectious Diseases Molecular Diagnostics Kit Product Offered
11.10.3 Agilent Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Agilent Main Business Overview
11.10.5 Agilent Latest Developments
11.11 Genomic Health
11.11.1 Genomic Health Company Information
11.11.2 Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Offered
11.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Genomic Health Main Business Overview
11.11.5 Genomic Health Latest Developments
11.12 BD
11.12.1 BD Company Information
11.12.2 BD Infectious Diseases Molecular Diagnostics Kit Product Offered
11.12.3 BD Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 BD Main Business Overview
11.12.5 BD Latest Developments
11.13 Foundation Medicine
11.13.1 Foundation Medicine Company Information
11.13.2 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Offered
11.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Foundation Medicine Main Business Overview
11.13.5 Foundation Medicine Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Polymerase Chain Reaction PCR
Table 3. Major Players of Molecular Hybridization
Table 4. Major Players of Biochip
Table 5. Major Players of Others
Table 6. Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 9. Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 12. Global Infectious Diseases Molecular Diagnostics Kit Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Player (2019-2024)
Table 14. Infectious Diseases Molecular Diagnostics Kit Key Players Head office and Products Offered
Table 15. Infectious Diseases Molecular Diagnostics Kit Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Regions (2019-2024)
Table 20. Global Infectious Diseases Molecular Diagnostics Kit Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Country (2019-2024)
Table 24. Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 26. Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 28. APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Region (2019-2024)
Table 30. APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 32. APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 34. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Country (2019-2024)
Table 36. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 38. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Infectious Diseases Molecular Diagnostics Kit
Table 47. Key Market Challenges & Risks of Infectious Diseases Molecular Diagnostics Kit
Table 48. Key Industry Trends of Infectious Diseases Molecular Diagnostics Kit
Table 49. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Roche Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 54. Roche Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 55. Roche Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. Qiagen Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 59. Qiagen Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 60. Qiagen Main Business
Table 61. Qiagen Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Qiagen Latest Developments
Table 63. Illumina Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 64. Illumina Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 65. Illumina Main Business
Table 66. Illumina Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Illumina Latest Developments
Table 68. Abbott Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 69. Abbott Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 70. Abbott Main Business
Table 71. Abbott Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Abbott Latest Developments
Table 73. Hologic Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 74. Hologic Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 75. Hologic Main Business
Table 76. Hologic Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Hologic Latest Developments
Table 78. BioMerieux Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 79. BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 80. BioMerieux Main Business
Table 81. BioMerieux Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. BioMerieux Latest Developments
Table 83. Danaher (Cepheid) Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 84. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 85. Danaher (Cepheid) Main Business
Table 86. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Danaher (Cepheid) Latest Developments
Table 88. Myriad Genetics Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 89. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 90. Myriad Genetics Main Business
Table 91. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Myriad Genetics Latest Developments
Table 93. DAAN Gene Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 94. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 95. DAAN Gene Main Business
Table 96. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. DAAN Gene Latest Developments
Table 98. Agilent Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 99. Agilent Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 100. Agilent Main Business
Table 101. Agilent Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Agilent Latest Developments
Table 103. Genomic Health Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 104. Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 105. Genomic Health Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Genomic Health Main Business
Table 107. Genomic Health Latest Developments
Table 108. BD Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 109. BD Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 110. BD Main Business
Table 111. BD Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. BD Latest Developments
Table 113. Foundation Medicine Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 114. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 115. Foundation Medicine Main Business
Table 116. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Foundation Medicine Latest Developments
Table 1. Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Polymerase Chain Reaction PCR
Table 3. Major Players of Molecular Hybridization
Table 4. Major Players of Biochip
Table 5. Major Players of Others
Table 6. Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 9. Infectious Diseases Molecular Diagnostics Kit Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 12. Global Infectious Diseases Molecular Diagnostics Kit Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Player (2019-2024)
Table 14. Infectious Diseases Molecular Diagnostics Kit Key Players Head office and Products Offered
Table 15. Infectious Diseases Molecular Diagnostics Kit Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Infectious Diseases Molecular Diagnostics Kit Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Regions (2019-2024)
Table 20. Global Infectious Diseases Molecular Diagnostics Kit Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Country (2019-2024)
Table 24. Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 26. Americas Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 28. APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Region (2019-2024)
Table 30. APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 32. APAC Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 34. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Country (2019-2024)
Table 36. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 38. Europe Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Infectious Diseases Molecular Diagnostics Kit
Table 47. Key Market Challenges & Risks of Infectious Diseases Molecular Diagnostics Kit
Table 48. Key Industry Trends of Infectious Diseases Molecular Diagnostics Kit
Table 49. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Infectious Diseases Molecular Diagnostics Kit Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Roche Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 54. Roche Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 55. Roche Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. Qiagen Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 59. Qiagen Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 60. Qiagen Main Business
Table 61. Qiagen Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Qiagen Latest Developments
Table 63. Illumina Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 64. Illumina Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 65. Illumina Main Business
Table 66. Illumina Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Illumina Latest Developments
Table 68. Abbott Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 69. Abbott Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 70. Abbott Main Business
Table 71. Abbott Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Abbott Latest Developments
Table 73. Hologic Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 74. Hologic Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 75. Hologic Main Business
Table 76. Hologic Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Hologic Latest Developments
Table 78. BioMerieux Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 79. BioMerieux Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 80. BioMerieux Main Business
Table 81. BioMerieux Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. BioMerieux Latest Developments
Table 83. Danaher (Cepheid) Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 84. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 85. Danaher (Cepheid) Main Business
Table 86. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Danaher (Cepheid) Latest Developments
Table 88. Myriad Genetics Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 89. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 90. Myriad Genetics Main Business
Table 91. Myriad Genetics Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Myriad Genetics Latest Developments
Table 93. DAAN Gene Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 94. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 95. DAAN Gene Main Business
Table 96. DAAN Gene Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. DAAN Gene Latest Developments
Table 98. Agilent Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 99. Agilent Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 100. Agilent Main Business
Table 101. Agilent Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Agilent Latest Developments
Table 103. Genomic Health Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 104. Genomic Health Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 105. Genomic Health Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Genomic Health Main Business
Table 107. Genomic Health Latest Developments
Table 108. BD Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 109. BD Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 110. BD Main Business
Table 111. BD Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. BD Latest Developments
Table 113. Foundation Medicine Details, Company Type, Infectious Diseases Molecular Diagnostics Kit Area Served and Its Competitors
Table 114. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Product Offered
Table 115. Foundation Medicine Main Business
Table 116. Foundation Medicine Infectious Diseases Molecular Diagnostics Kit Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Foundation Medicine Latest Developments
LIST OF FIGURES
Figure 1. Infectious Diseases Molecular Diagnostics Kit Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Infectious Diseases Molecular Diagnostics Kit Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country/Region (2023)
Figure 8. Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type in 2023
Figure 10. Infectious Diseases Molecular Diagnostics Kit in Hospital
Figure 11. Global Infectious Diseases Molecular Diagnostics Kit Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Infectious Diseases Molecular Diagnostics Kit in Third-party Testing Agency
Figure 13. Global Infectious Diseases Molecular Diagnostics Kit Market: Third-party Testing Agency (2019-2024) & ($ Millions)
Figure 14. Infectious Diseases Molecular Diagnostics Kit in Others
Figure 15. Global Infectious Diseases Molecular Diagnostics Kit Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application in 2023
Figure 17. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Player in 2023
Figure 18. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2024 ($ Millions)
Figure 20. APAC Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2024 ($ Millions)
Figure 21. Europe Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2024 ($ Millions)
Figure 23. Americas Infectious Diseases Molecular Diagnostics Kit Value Market Share by Country in 2023
Figure 24. United States Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Region in 2023
Figure 29. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type in 2023
Figure 30. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application in 2023
Figure 31. China Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Country in 2023
Figure 38. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Figure 39. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Figure 40. Germany Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 54. APAC Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 55. Europe Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 57. United States Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 58. Canada Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 61. China Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 62. Japan Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 63. Korea Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 65. India Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 66. Australia Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 67. Germany Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 68. France Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 69. UK Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 70. Italy Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 71. Russia Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 72. Spain Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 75. Israel Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 78. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Infectious Diseases Molecular Diagnostics Kit Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Infectious Diseases Molecular Diagnostics Kit Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Infectious Diseases Molecular Diagnostics Kit Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country/Region (2023)
Figure 8. Infectious Diseases Molecular Diagnostics Kit Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type in 2023
Figure 10. Infectious Diseases Molecular Diagnostics Kit in Hospital
Figure 11. Global Infectious Diseases Molecular Diagnostics Kit Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Infectious Diseases Molecular Diagnostics Kit in Third-party Testing Agency
Figure 13. Global Infectious Diseases Molecular Diagnostics Kit Market: Third-party Testing Agency (2019-2024) & ($ Millions)
Figure 14. Infectious Diseases Molecular Diagnostics Kit in Others
Figure 15. Global Infectious Diseases Molecular Diagnostics Kit Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application in 2023
Figure 17. Global Infectious Diseases Molecular Diagnostics Kit Revenue Market Share by Player in 2023
Figure 18. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2024 ($ Millions)
Figure 20. APAC Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2024 ($ Millions)
Figure 21. Europe Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size 2019-2024 ($ Millions)
Figure 23. Americas Infectious Diseases Molecular Diagnostics Kit Value Market Share by Country in 2023
Figure 24. United States Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Region in 2023
Figure 29. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type in 2023
Figure 30. APAC Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application in 2023
Figure 31. China Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Country in 2023
Figure 38. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Figure 39. Europe Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Figure 40. Germany Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Infectious Diseases Molecular Diagnostics Kit Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 54. APAC Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 55. Europe Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 57. United States Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 58. Canada Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 61. China Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 62. Japan Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 63. Korea Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 65. India Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 66. Australia Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 67. Germany Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 68. France Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 69. UK Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 70. Italy Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 71. Russia Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 72. Spain Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 75. Israel Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Infectious Diseases Molecular Diagnostics Kit Market Size 2025-2030 ($ Millions)
Figure 78. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Infectious Diseases Molecular Diagnostics Kit Market Size Market Share Forecast by Application (2025-2030)
